J4 ›› 2009, Vol. 35 ›› Issue (4): 650-655.

• 基础研究 • 上一篇    下一篇

白血病耐药细胞中多药耐药基因MDR1与核转录因子κB的关系

杨冬艳1, 张宏宇2, 孔晓霞2, 孙连坤2, 史纪文1   

  1. 1.吉林大学中日联谊医院超声科| |吉林 长春 130033;2.吉林大学基础医学院病理生理学教研室| |吉林 长春 130021
  • 收稿日期:2008-11-28 出版日期:2009-07-28 发布日期:2009-08-24
  • 通讯作者: 史纪文 E-mail:yangdongyan2850@163.com
  • 作者简介:杨冬艳(1969-)|女|吉林省长春市人|副教授|医学博士,主要从事介入超声治疗方面的研究。
  • 基金资助:

    吉林省科技厅科技发展计划项目资助课题(200705373)

Relationship between multi-drug resistance gene MDR1 and NF-kappa B  in human drug-resistance erythroleukemia cells

 YANG Dong-Yan1, ZHANG Hong-Yu2, KONG Xiao-Xia2, SUN Lian-Kun2, SHI Ji-Wen1   

  1. 1.Department of Ultrasound,China-Japan Union Hospital,Jilin University,Changchun 130033,China;2.Department of Pathphysiology, School of Basic Medical Sciences,Jilin University,Changchun 130021,China
  • Received:2008-11-28 Online:2009-07-28 Published:2009-08-24

摘要:

目的:研究核转录因子κB与多药耐药基因MDR1在白血病化疗耐药中的作用,阐明核转录因子κB(NF-κB)与白血病多药耐药的关系及相关分子机制。方法:白血病细胞K562和阿霉素(ADM)诱导的耐药细胞K562/ADM分别应用ADM(0、0.25、0.50、1.00和2.00  μg·L-1)或丝裂霉素(MIT)(0、2、4、8和16 mg·L-1) 作用48 h,通过MTT法检测细胞生存率,计算细胞耐药指数;RT-PCR方法检测MDR1和IκB mRNA表达;Western blotting方法检测P-gp和P65的蛋白表达。结果:ADM和MIT分别作用后,与空白对照组比较,白血病细胞K562细胞生存率下降(P<0.01),呈剂量依赖性;ADM和MIT对耐药细胞K562/ADM生存率作用不明显;在mRNA水平上,与K562细胞比较,K562/ADM细胞的MDR1 mRNA高表达(P<0.01)。与空白对照组比较,ADM 0.50和1.00   μg·L-1>或MIT 4和8  mg·L-1分别作用K562细胞和K562/ADM细胞,IκBα mRNA表达均下降(P<0.01),并呈剂量依赖性;在蛋白水平上,与K562细胞比较,K562/ADM细胞的P-gp蛋白高表达(P<0.01)。与空白对照组比较,ADM 0.50和1.00  μg·L-1或MIT 4和8 mg·L-1分别作用K562/ADM细胞,P-gp蛋白表达量升高(P<0.01),同时P65蛋白表达量升高,且呈药物剂量依赖性(P<0.01)。结论:MDR1基因及P-gp蛋白的高表达很可能是白血病细胞K562多药耐药性形成的关键机制,而NF-κB的激活可能参与了多药耐药的调控。

关键词: 多药耐药基因;核转录因子κB;P65

Abstract:

Objective
To observe the effect of nuclear factor kappa B (NF-κB) and multi-drug resistance gene MDR1 on leukemia chemotherapy resistance,to demonstrate the relationship between  NF-κB and multidrug-resistance and the related mechanism.Methods  Erythroleukemia cells K562 and adriamycin(ADM)-resistance cells K562/ADM were treated with  ADM (0,0.25,0.50,1.00,2.00   μg·L-1) or mitomycin (MIT)(0,2,4,8,16 mg·L-1) for 48 h. The cell viability was detected by MTT assay,the cell resistant factor was calculated,MDR1 and IκB mRNA levels were detected by RT-PCR;P-gp and  P65 protein levels were detected by Western blotting.
Results Compared with control group,0.50 and 1.00   μg·L-1 ADM or 4 and 8 mg·L-1  MIT inhibited the cell viability significantly in erythroleukemia cells K562 in a dose-dependent manner (P<0.01);but had no significant effect on drug-resistance cells;on the mRNA level,compared with K562 cells,the  expression level of MDR1 mRNA in K562/ADM cells was higher(P<0.01).Compared with control group,the expressions of  IκBα mRNA decreased(P<0.01)  in K562 cells or K562/ADM cells treated with  0.50 and 1.00   μg·L-1 ADM  or 4 and 8 mg·L-1  MIT respectively in a dose-dependent manner.On the protein level,compared with K562 cells,the expression of P-gp protein increased(P<0.01);compared with control group,the expression of P-gp protein  increased (P<0.01),the expression of P65 protein increased at the same time  in a  dose-dependent manner in K562/ADM cells treated with 0.50 and 1.00 μg·L-1 ADM or 4 and 8 mg·L-1 MIT(P<0.01).Conclusion The high  expression of MDR1 gene and P-gp protein may be the essential mechanism of drug resistance in K562 cells,and the activation of NF-κB may be involved in the regulation of multi-drug resistance.

Key words: multi-drug resistance gene;nuclear factor κB;P65

中图分类号: 

  •